SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about outcome of board meeting

06 Dec 2025 Evaluate

Welcure Drugs & Pharmaceuticals has informed that the Board of Directors of the Company in its meeting held today, Saturday, December 06, 2025, at the registered office of the Company has reviewed and approved various decisions pertaining to the Company’s past business operations and investment-related matters- Execution of Letter of Intent (LOI) with Telexcell Trade PTE LTD, Singapore for Equity Investment; Proposed Agro-Pharma Research Laboratory & Board Meeting held on 28 August 2025 to consider fund-raising by QIP.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.30 0.01 (3.45%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 223.40
Adani Enterprises 2539.40
Amrapali Industries 18.69
Rashi Peripheral 500.90
PDS 288.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×